You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

EPINEPHRINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Epinephrine, and what generic alternatives are available?

Epinephrine is a drug marketed by Armstrong Pharms, Am Regent, Bpi Labs, Intl Medication Sys, Hospira, and Teva Pharms Usa. and is included in eight NDAs. There are three patents protecting this drug and one Paragraph IV challenge.

The generic ingredient in EPINEPHRINE is epinephrine. There are twenty-one drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the epinephrine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Epinephrine

A generic version of EPINEPHRINE was approved as epinephrine by BPI LABS on July 29th, 2014.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for EPINEPHRINE?
  • What are the global sales for EPINEPHRINE?
  • What is Average Wholesale Price for EPINEPHRINE?
Drug patent expirations by year for EPINEPHRINE
Drug Prices for EPINEPHRINE

See drug prices for EPINEPHRINE

Drug Sales Revenue Trends for EPINEPHRINE

See drug sales revenues for EPINEPHRINE

Paragraph IV (Patent) Challenges for EPINEPHRINE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
EPINEPHRINE Injection epinephrine 1 mg/mL 205029 1 2020-08-13
ADRENALIN Injection epinephrine 30 mg/30 mL 204640 1 2018-08-20
ADRENALIN Injection epinephrine 1 mg/mL ampules 204200 1 2016-03-09
EPIPEN JR. Injection (Auto- injector) epinephrine 0.15 mg/0.3 mL and 0.3 mg/0.3 mL 019430 1 2009-07-20

US Patents and Regulatory Information for EPINEPHRINE

EPINEPHRINE is protected by five US patents.

Patents protecting EPINEPHRINE

More potent and less toxic formulations of epinephrine and methods of medical use
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: EMERGENCY TREATMENT OF ALLERGIC REACTIONS (TYPE 1), INCLUDING ANAPHYLAXIS; A METHOD OF TREATING ALLERGIC REACTION, ANAPHYLAXIS, ANAPHYLACTIC SHOCK, OR COMBINATION THEREOF BY AN INJECTION OF AT LEAST ONE DOSAGE OF THE INJECTABLE LIQUID PHARMACEUTICAL

More potent and less toxic formulations of epinephrine and methods of medical use
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: INCREASING MEAN ARTERIAL BLOOD PRESSURE IN ADULT PATIENTS WITH HYPOTENSION ASSOCIATED WITH SEPTIC SHOCK

More potent and less toxic formulations of epinephrine and methods of medical use
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: EMERGENCY TREATMENT OF ALLERGIC REACTIONS (TYPE I), INCLUDING ANAPHYLAXIS

More potent and less toxic formulations of epinephrine and methods of medical use
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: INCREASING MEAN ARTERIAL BLOOD PRESSURE IN ADULT PATIENTS WITH HYPOTENSION ASSOCIATED WITH SEPTIC SHOCK

More potent and less toxic formulations of epinephrine and methods of medical use
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: INDUCTION AND MAINTENANCE OF MYDRIASIS DURING INTRAOCULAR SURGERY

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Armstrong Pharms EPINEPHRINE epinephrine AEROSOL, METERED;INHALATION 087907-001 May 23, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Intl Medication Sys EPINEPHRINE epinephrine SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS 211880-001 Apr 24, 2020 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bpi Labs EPINEPHRINE epinephrine SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS 205029-005 Mar 4, 2024 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bpi Labs EPINEPHRINE epinephrine SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS 205029-001 Jul 29, 2014 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Bpi Labs EPINEPHRINE epinephrine SOLUTION;INTRAVENOUS 205029-003 May 12, 2023 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Pharms Usa EPINEPHRINE (AUTOINJECTOR) epinephrine INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS 090589-002 Aug 16, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.